Targeting Pdzrn3 maintains adult blood-brain barrier and central nervous system homeostasis

被引:8
|
作者
Gueniot, Florian [1 ]
Rubin, Sebastien [1 ]
Bougaran, Pauline [1 ]
Abelanet, Alice [1 ]
Morel, Jean Luc [2 ]
Bontempi, Bruno [2 ]
Proust, Carole [1 ]
Dufourcq, Pascale [1 ,3 ]
Couffinhal, Thierry [1 ,4 ]
Duplaa, Cecile [1 ]
机构
[1] Univ Bordeaux, Biol Cardiovasc Dis, U1034, Bordeaux, France
[2] Univ Bordeaux, IMN, CNRS, UMR 5293, Bordeaux, France
[3] CHU Bordeaux, Serv Biochim Clin, Bordeaux, France
[4] CHU Bordeaux, Serv Malad Cardiaques & Vasc, Bordeaux, France
关键词
Vascular cognitive impairment; blood brain barrier; vascular permeability; Wnt pathway; endothelial tight junction; ALZHEIMERS-DISEASE; NEUROVASCULAR UNIT; VASCULAR DEVELOPMENT; MOUSE MODEL; IMPAIRMENT; DISRUPTION; PHENOTYPE; BREAKDOWN; CNS;
D O I
10.1177/0271678X211048981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blood brain barrier (BBB) disruption is a critical component of the pathophysiology of cognitive impairment of vascular etiology (VCI) and associated with Alzheimer's disease (AD). The Wnt pathway plays a crucial role in BBB maintenance, but there is limited data on its role in cognitive pathologies. The E3 ubiquitin ligase PDZRN3 is a regulator of the Wnt pathway. In a murine model of VCI, overexpressing Pdzrn3 in endothelial cell (EC) exacerbated BBB hyperpermeability and accelerated cognitive decline. We extended these observations, in both VCI and AD models, showing that EC-specific depletion of Pdzrn3, reinforced the BBB, with a decrease in vascular permeability and a subsequent spare in cognitive decline. We found that in cerebral vessels, Pdzrn3 depletion protects against AD-induced Wnt target gene alterations and enhances endothelial tight junctional proteins. Our results provide evidence that Wnt signaling could be a molecular link regulating BBB integrity and cognitive decline under VCI and AD pathologies.
引用
收藏
页码:613 / 629
页数:17
相关论文
共 50 条
  • [21] Nogo-A neutralization in the central nervous system with a blood-brain barrier-penetrating antibody
    Joly, Sandrine
    Augusto, Gilles
    Mdzomba, Baya
    Meli, Ivo
    Vogel, Monique
    Chan, Andrew
    Pernet, Vincent
    JOURNAL OF CONTROLLED RELEASE, 2024, 366 : 52 - 64
  • [22] GPR126 is a specifier of blood-brain barrier formation in the mouse central nervous system
    Kakogiannos, Nikolaos
    Scalise, Anna Agata
    Martini, Emanuele
    Maderna, Claudio
    Benvenuto, Andrea Francesco
    D'Antonio, Michele
    Carmignani, Laura
    Magni, Serena
    Gullotta, Giorgia Serena
    Lampugnani, Maria Grazia
    Iannelli, Fabio
    Beznoussenko, Galina, V
    Mironov, Alexander A.
    Cerutti, Camilla
    Bentley, Katie
    Philippides, Andrew
    Zanardi, Federica
    Bacigaluppi, Marco
    Sigismund, Sara
    Bassani, Claudia
    Farina, Cinthia
    Martino, Gianvito
    De Giovanni, Marco
    Dejana, Elisabetta
    Iannacone, Matteo
    Inverso, Donato
    Giannotta, Monica
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (15)
  • [23] An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma
    Zhao, Meifang
    Li, Qi
    Chai, Yali
    Rong, Rong
    He, Lexin
    Zhang, Yuchen
    Cui, Hongxia
    Xu, Hao
    Zhang, Xinyun
    Wang, Zhiming
    Yuan, Shushu
    Chen, Menglu
    He, Chuan
    Zhang, Han
    Qin, Linlin
    Hu, Ruijing
    Zhang, Xinyuan
    Zhuang, Wenzhuo
    Li, Bingzong
    JOURNAL OF NANOBIOTECHNOLOGY, 2025, 23 (01)
  • [24] Central nervous system complications of diabetes mellitus - A perspective from the blood-brain barrier
    Mooradian, AD
    BRAIN RESEARCH REVIEWS, 1997, 23 (03) : 210 - 218
  • [25] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
    Alavijeh M.S.
    Chishty M.
    Qaiser M.Z.
    Palmer A.M.
    NeuroRX, 2005, 2 (4): : 554 - 571
  • [26] Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System
    Mustafa, Yasmin Mucuna
    Meuren, Lana Monteiro
    Antunes Coelho, Sharton Vinicius
    de Arruda, Luciana Barros
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [27] Targeted Analysis of Central Nervous System Using Blood-Brain Barrier Shuttle Peptides
    Huang Yan-Yan
    Zhao Rui
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2019, 47 (10) : 1629 - 1638
  • [28] Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions
    Chapouly, Candice
    Argaw, Azeb Tadesse
    Horng, Sam
    Castro, Kamilah
    Zhang, Jingya
    Asp, Linnea
    Loo, Hannah
    Laitman, Benjamin M.
    Mariani, John N.
    Farber, Rebecca Straus
    Zaslavsky, Elena
    Nudelman, German
    Raine, Cedric S.
    John, Gareth R.
    BRAIN, 2015, 138 : 1548 - 1567
  • [29] Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood-brain barrier
    Wang, Xiang
    Yin, Yue
    Zhou, Huaijuan
    Chi, Bowen
    Guan, Ling
    Li, Pei
    Li, Jinhua
    Wang, Yilong
    EXPLORATION, 2024,
  • [30] Microglia in the Neurovascular Unit: Blood-Brain Barrier-microglia Interactions After Central Nervous System Disorders
    Thurgur, Hannah
    Pinteaux, Emmanuel
    NEUROSCIENCE, 2019, 405 : 55 - 67